Flow cytometry analysis of tumor‐infiltrating CD8+ T cells revealed that cotreatment with V‐9302 and anti‐PD‐1 significantly enhanced the expression of cytolytic proteins (GZMB and PRF1) and effector cytokines (IFN‐γ and TNF‐α) compared to monotherapy groups. Here, PDCD1 is linked to neoplasm.